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Background: Catheter based renal artery denervation has demonstrated to be effective in
decreasing blood pressure among patients with refractory hypertension. The anatomical
distribution of renal artery nerves may influence the safety and efficacy profile of this
procedure. We aimed to describe the anatomical distribution and density of renal artery
nerves in the porcine model.
Methods: A total 8 porcine renal arteries were included in the analysis. A tissue block
containing the renal arteries and peri-renal tissue was extracted. Each artery was divided
into 3 individual segments (proximal, mid and distal) and stained for histological analysis.
Histological sections were assessed for total number, size (0-50 m, 50-100m, 100-200
m, 200-500 m) and depth (1 to 6 mm from renal artery) of the nerves according to the
location. Immunohistochemistry, targeting tyrosine hydroxylase (efferent nerve fibers
[ENF]) and calcitonin gene related peptide (CGRP, afferent nerve fibers [ANF]) was
performed in a mid-section.
Results: Nerve counts were greatest proximally (57.2% of the total nerves) and decreased
gradually distally (23.5%in mid-sections and 19.3% in distal sections). The distribution in
nerve size was similar across all three sections (40% of the nerves 50-100 m,30%
of the nerves 0-50 m,20% of the nerves 100-200 m and10% of the nerves
200-500 m). In the proximal segments 33% of the nerves were located within 2-mm
from the arterial wall. In the mid (28%) and distal segments (42%) were located within
1-mm from the arterial wall. Sympathetic efferent fibers overwhelmingly outnumbered
sensory afferent fibers. The afferent and efferent fibers were frequently intermixed within
the nerve bundle.
Conclusions: In the porcine model, renal artery nerves are more frequently seen in the
proximal segment of the artery. Nerve size distribution appears to be homogeneous
throughout the artery length. Nerve bundles progress closer to the arterial wall in the distal
segments of the artery. This anatomical distribution may have implications for the future
development of renal denervation therapies.
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Background: The long term outcome of stent malapposition after stent implantation
remains unclear. The aim of this study was to evaluate serial changes of stent
malapposition after everolims-eluting stent implantation by using optical coherence
tomography (OCT).
Methods: Randomized Evaluation of Sirolims-eluting versus Everolims-eluting stent
Trial (RESET) was a prospective dual-arm randomized trial of everolims-eluting stents
and sirolims-eluting stents in 3200 patients with coronary artery disease. From the RESET
trial, 70 patients with everolims-eluting stents who underwent serial OCT examination
(post-stenting and 12-month follow-up) were investigated.
Results: At post-stenting, acute stent malapposition was observed in 23 (32%) everolims-
eluting stents, and 115 malapposed stent struts were detected. Mean stent malapposed
distance (distance from stent strut to lumen surface) was 210  240 m at post-stenting.
At 12-month follow-up, 15 (65%) stent malapposition was resolved, however 8 (35%)
stent malapposition was persistent. A total of 41 persistent malapposed stent struts were
detected, and mean stent malapposed distance was 110 190 m at 12-month follow-up.
The ROC curves showed that stent malapposed distance  290m at post-stenting was
the best cut-off to predict persistent stent malapposition at 12-month follow-up in
everolims-eluting stents.
Conclusions: The stent with malapposed distance  290m at post-stenting has a high
risk for persistent stent malapposition at 12-month follow-up in everolims-eluting stents.
OCT can predict persistent stent malapposition and provide useful information to optimize
percutaneous coronary intervention.
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Background: Discordance between Fractional Flow Reserve(FFR) and Coronary Flow
Reserve(CFVR) reflects divergent extremes of focal epicardial and small vessel disease.
Discordance is ignored in daily clinical practice, although it occurs in 30% of intermediate
lesions, and data on its relevance for long-term clinical outcome is lacking.
Methods: We studied intermediate coronary lesions that were evaluated by FFR and
CFVR between April 1997 and September 2006. Treatment was deferred when non-
invasive testing was negative or non-diagnostic. Ten year follow up was performed to
document the occurrence of major adverse cardiac events (MACE): cardiac death,
non-fatal myocardial infarction, or target vessel revascularization.
Results: FFR and CFVR were evaluated in 191 deferred coronary lesions. Discordance
was present with FFR0.75 and CFVR 2.0 in 24 lesions (13%), and FFR0.75 and
CFVR 2.0 in 29 lesions (15%). MACE related to 80 lesions (42%). Ten-year Kaplan
Meier (KM) estimates of MACE were higher for discordant lesions compared to
concordant negative lesions: 27% in concordant lesions, versus 52% when FFR0.75 and
CFVR2.0 and 51.0% when FFR0.75 and CFVR2.0 (P0.01 versus concordant
negative for both). Importantly, KM-estimates of 10-year MACE did not differ between
both groups of discordance(Figure).
Conclusions: Deferral of lesions with discordant results between FFR and CFVR is
associated with an increase in long-term MACE compared tot concordant negative results,
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irrespective of whether FFR or CFVR is ischemic. This underscores the requirement of
both flow and pressure assessment for optimal risk stratification.
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Background: Non-invasive fractional flow reserve (FFR) derived from typically
acquired coronary computed tomographic (CT) angiography (FFRCT) is a novel method
that employs computational fluid dynamics to diagnose coronary lesions that cause
ischemia. To date, the diagnostic performance of FFRCT versus CT stenosis to effectively
diagnose ischemia in vessels with stenosis of intermediate severity (30-70% luminal
diameter stenosis) has been inadequately studied.
Methods: Amongst 407 vessels from 252 patients at 17 centers in 4 countries who
underwent CT, FFRCT, invasive coronary angiography and invasive FFR, we identified
150 vessels of intermediate stenosis severity by CT. CT stenosis, FFRCT, and invasive
FFR were interpreted in blinded fashion by independent core laboratories. FFRCT and
FFR 0.80 were considered ischemic, while CT stenosis 50% were considered
obstructive. Diagnostic performance of CT stenosis alone versus FFRCT alone were
evaluated for sensitivity, specificity, positive predictive value (PPV), and negative
predictive value (NPV); as well as employing a decision rule combining FFRCT and CT
stenosis wherein maximal per-patient CT stenosis 30% was considered negative for
ischemia and subtotal or total occlusions were considered positive for ischemia. Area
under the receiver operating characteristics curve for FFRCT and CT stenosis were
compared for discrimination.
Results: For lesions of intermediate stenosis severity, FFRCT demonstrated a sensitivity,
specificity, PPV and NPV of 74%, 66%, 40%, and 89%; while CT stenosis demonstrated
a sensitivity, specificity, PPV and NPV of 34%, 72%, 27%, 78%. When applying the
decision rule, the combination of FFRCT and CT stenosis resulted in a sensitivity,
specificity, PPV and NPV of 74%, 67%, 39% and 90%. The AUC of FFRCT for
discrimination of ischemia in stenoses of intermediate severity was higher than CT
stenosis (0.80 vs. 0.55, p0.0001), with no added improvement when CT stenosis was
added to FFRCT (0.81 vs. 0.80).
Conclusions: Compared to CT, FFRCT possesses higher diagnostic performance for
lesions of intermediate severity, with a 2X increase in sensitivity and superior NPV,
suggesting its role to identify lesions that are not ischemic.
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Background: Previous IVUS studies examining correlates of drug-eluting stent (DES)
thrombosis were retrospective and in small patient cohorts.
Methods: ADAPT-DES was a prospective, multicenter, real-world registry of 8,575
consecutive pts at 11 international centers treated with percutaneous coronary intervention
(PCI) using DES designed to determine the frequency, timing, and correlates (clinical,
angiographic and platelet reactivity) of early and late DES thrombosis. A pre-specified
IVUS substudy enrolled 2,438 IVUS-guided PCI lesions in 2,064 pts; baseline grayscale
volumetric IVUS analysis was prospectively done at an independent core laboratory, and
1-year follow-up was completed.
Results: Average pt age was 64.0 years and 75.4% were male. Stent thrombosis (ST)
occurred in 10 pts (0.5%); 7 definite and 3 probable (median 14.5 days). ST lesions had
more attenuated plaque – a grayscale IVUS marker of a large necrotic core or a thin-cap
fibroatheroma - along with greater tissue protrusion through the stent into the lumen,
reference plaque burden and edge dissections (Table). Minimum lumen area, stent
expansion, and acute malapposition were similar in ST vs no ST.
ST (n10) No ST (n2428) p value
Stent length, mm 32.6 [22.7, 55.0] 23.8 [17.1, 33.7] 0.16
Minimum lumen area
(MLA), mm2
5.4 [4.4, 7.5] 5.8 [4.5, 7.6] 0.82
Stent expansion (MSA/
reference lumen area), %
69.9 [58.2, 86.7] 73.1 [62.1, 84.4] 0.68
Post-stent abluminal plaque
burden, %
58.6 [50.9, 61.5] 51.7 [47.1, 56.2] 0.09
Proximal reference plaque
burden, %
57.8 [48.2, 70.9] 45.4 [38.4, 53.0] 0.02
Lesions with intra-stent
tissue protrusion, %
50% (5/10) 34.3% (834/2428) 0.33
Maximum tissue protrusion
area, mm2
1.9 [1.3, 2.1] 0.7 [0.5, 1.2] 0.02
Lesions with attenuated
plaque behind stent, %
80% (8/10) 62.5% (1517/2428) 0.34
Maximum attenuated
plaque arc, °
118 [83, 155] 80 [50,110] 0.04
Total attenuated plaque
length, mm
17.7 [5.6, 23.1] 5.8 [2.9, 11.1] 0.01
Proximal reference
attenuated plaque, %
60% (6/10) 26.6% (586/2200) 0.03
Distal edge dissection
(deeper than media), %
25% (2/8) 2.5% (58/2360) 0.02
Stent malapposition, % 20% (2/10) 15.9% (387/2428) 0.67
Conclusions: In the present analysis from the largest prospective IVUS study to date, the
presence of attenuated plaque, tissue protrusion, reference segment plaque burden and
edge dissections were significant predictors of ST, whereas underexpansion and malap-
position were not. This highlights the complex relationship between underlying lesion
morphology, PCI results and outcomes in pts treated with DES.
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Background: Whether IVUS guidance reduces stent thrombosis and improves clinical
outcomes after DES is unknown, with only small observational studies and no random-
ized trials having been reported.
Methods: ADAPT-DES was a prospective, multicenter, real-world registry of 8,576
consecutive pts at 11 international centers undergoing percutaneous coronary intervention
(PCI) with DES designed to determine the frequency, timing, and correlates (clinical,
angiographic and platelet reactivity) of early and late stent thrombosis. During the index
procedure, IVUS was used in 3,343 (39.0%) of cases and 1-year follow-up was
completed.
Results: Average pt age was 64.0 years and 74.1% were male. Patients in the IVUS
group were more likely to have ACS and high platelet reactivity to thienopyridine
(PRU208), and were treated with longer and larger stents, and more everolimus-eluting
stents. Within 1 year, definite/probable stent thrombosis (ST) occurred in 17 (0.52%) pts
in IVUS group vs in 53 (1.04%) pts in non-IVUS group (HR [95%CI] 0.37[0.20, 0.69],
p0.0016) (Table). In a propensity adjusted model to account for the predictors of IVUS
use, IVUS guidance was independently associated with a reduced 1-year rate of ST (HR
[95%CI]  0.37 [0.20, 0.68], p0.0014). All-cause death or MI also occurred signifi-
cantly less frequently in the IVUS group (Table) due to fewer cardiac deaths and non
peri-procedural MIs.
TUESDAY, OCTOBER 23, 10:30 AM–12:30 PM www.jacc.tctabstracts2012.com
B6 JACC Vol 60/17/Suppl B | October 22–26, 2012 | TCT Abstracts/ORAL/Adjunct Imaging and Physiology
O
R
A
L
S
